Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02221219 · ClinicalTrials.gov registry record · Phase 1

Effects of Delayed Cord Clamp and/or Indomethacin on Preterm Infant Brain Injury

A Phase 1 study of Intraventricular Hemorrhage and Brain Injury, sponsored by Hong Huang.

Completed
Registry status
Phase 1
Development phase
256
Enrollment target
1
Study location

NCT02221219 is a Phase 1 study of Intraventricular Hemorrhage and Brain Injury that has completed, run by Hong Huang. The registered enrollment target is 256 participants, below the 1,190-participant average among 11 other Intraventricular Hemorrhage trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02221219, a Phase 1 study of Intraventricular Hemorrhage and Brain Injury, has completed, sponsored by Hong Huang.

COMPLETED
Registry status
Phase 1
Development phase
256 participants
Enrollment target
1
Study location

Study Summary

Intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL) are brain lesions that commonly occur in preterm infants and are well-recognized major contributors to long-term brain injury and related disabilities later in life. Despite its prevalence, long term consequences, and enormous medical and social costs, mechanisms of IVH and optimal strategies to prevent or treat its occurrence are poorly defined, especially for extremely premature infants. Only one medical therapy, prophylactic indomethacin during the first 3 days of life, has been shown to prevent or decrease the severity of IVH in preterm infants, but its use is limited by toxic side effects and debatable effects on long-term outcomes. Several small studies and case reports suggest that delayed umbilical cord-clamping (DCC) may also decrease the incidence of IVH in premature infants, but thus far these trials have indomethacin treatment mixed within their cord clamping protocols. The investigators are conducting a randomized, blinded investigation of 4 treatment groups: 1) Control (no intervention); 2) DCC alone; 3) Prophylactic indomethacin alone; 4) Combination of DCC/indomethacin, with respect to survival, IVH or PVL incidence and severity, neurodevelopmental outcomes, and relevant mechanistic effects. With the steady rise in extreme prematurity births and clear links of IVH to long-term disabilities there is a need to improve care for these patients. This multi- disciplinary project addresses an important medical problem for an understudied patient population, where the current practice has clear limitations.

Interventions

  • DRUG Indomethacin
  • DRUG placebo infusion
  • PROCEDURE delay in umbilical cord clamp at birth
  • PROCEDURE immediate cord clamp at birth

Study Locations (1)

Kentucky

  • Kentucky Childrens Hospital Neonatal Intensive Care Unit - Lexington

Trial Details

FieldValue
Enrollment Target 256 participants
Start Date 2014-08
Est. Completion 2021-08-28
Phase Phase 1

Sponsor

Hong Huang

1 total trials

What the Registry Record Tells You About NCT02221219

The ClinicalTrials.gov registry entry for NCT02221219 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,190-participant average among 11 other Intraventricular Hemorrhage trials with a reported enrollment target (78% lower). The listed sponsor is Hong Huang, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Intraventricular Hemorrhage appearing as the primary indexed condition, and to 4 interventions - of which Indomethacin is the first listed.

NCT02221219 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT02221219 about?

NCT02221219 is a clinical study titled "Effects of Delayed Cord Clamp and/or Indomethacin on Preterm Infant Brain Injury". Intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL) are brain lesions that commonly occur in preterm infants and are well-recognized major contributors to long-term brain injury and related disabilities later in life. Despite its prevalence, long term consequences, and enormous ...

What is the current status of trial NCT02221219?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 256 participants. The study started on 2014-08. Estimated completion is 2021-08-28.

What conditions does trial NCT02221219 study?

This clinical trial studies the following conditions: Intraventricular Hemorrhage, Brain Injury, Periventricular Leukomalacia, Renal Injury.

What interventions are being tested in trial NCT02221219?

The interventions under investigation include: Indomethacin (DRUG), placebo infusion (DRUG), delay in umbilical cord clamp at birth (PROCEDURE), immediate cord clamp at birth (PROCEDURE).

Who is sponsoring clinical trial NCT02221219?

This trial is sponsored by Hong Huang, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02221219 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intraventricular Hemorrhage

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.